Educational activity for Nurses on Biosimilar Medicines

(Accreditation coming soon)

This activity addresses the following learning outcomes using a combination of reading and active listening to video content.

Learning objectives

EXPERTISE	Explain how biosimilar medicines contribute to the sustainability of the Australian healthcare system Outline the clinical development and regulatory processes required prior to approval of biosimilar medicines
PATIENT CARE	Explain to patients what a biosimilar medicine is, why it is different to a generic medicine, and their therapeutic equivalence to the reference biological product Provide evidence-based information to manage patient concerns and queries surrounding biosimilar medicines
PRACTICE	Understand the criteria that must be met in order to substitute a PBS-subsidised reference biological for a biosimilar medicine at the point of dispensing